Results 251 to 260 of about 348,149 (303)
RNA-Based Therapies for Inherited Metabolic Disorders. [PDF]
Vootukuri RS +5 more
europepmc +1 more source
LINC00473 modulates protein expression to promote ovarian cancer progression and overcome cisplatin resistance. [PDF]
Zhang C +6 more
europepmc +1 more source
Cholesterol-dependent control of endosomal escape regulates intracellular trafficking of small interfering RNA therapeutics and interactions with small molecule drugs. [PDF]
Tawfik SM +4 more
europepmc +1 more source
RNA G-quadruplexes in oncogene regulation and as emerging targets for cancer therapy. [PDF]
Liu ZY +6 more
europepmc +1 more source
STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation. [PDF]
Zhao R, Fang K, Zhang X, Li H.
europepmc +1 more source
Estrogen receptor (ESR) 1 promotes uterine leiomyoma cell proliferation by enhancing mitochondrial energy metabolism via Wnt/β-catenin pathway activation. [PDF]
Wu Q +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Small interfering RNA (siRNA)-based therapeutics
Drug and Therapeutics Bulletin, 2023In early studies in simple organisms and mammalian cell lines, small interfering RNA (siRNA) molecules were found to allow experimental cleavage of intracellular messenger RNA (mRNA; the transcription product of a cell gene), reducing the levels of the proteins that would otherwise be formed by the action of the mRNA, thereby ‘silencing’ a specific ...
openaire +2 more sources

